Research Article
Xiaoqinglong Granules as Add-On Therapy for Asthma: Latent Class Analysis of Symptom Predictors of Response
Table 3
Subject demographics and baseline characteristics (ITT population).
| | | XQLG add-on group () | Placebo add-on group () |
| | Age, year, mean (SD) | 44.13 (12.42) | 44.20 (11.92) | | Sex, n male (%) | 34 (40.48) | 46 (53.49) | | BMI, kg/m2, mean (SD) | 22.66 (3.22) | 22.72 (2.83) | | GATPC | | | | II | 45 (53.57) | 44 (51.16) | | III | 39 (46.43) | 42 (48.84) | | Duration of disease, year, mean (minimum, maximum) | 10.83 (0.00,52.00) | 11.24 (0.00,54.00) | | FEV1 (%), mean (SD) | 75.60 (25.91) | 72.45 (22.61) | | PEF, L/min, mean (SD) | 282. 71 (135.84) | 282.31 (20.92) | | ACT, mean score (SD) | 16.86 (3.67) | 16.94 (3.57) |
|
|
Definition of abbreviations: GATPC: guideline of asthma treatment and prevention in China; ACT: asthma control test; ITT: intent-to-treat.
|
